Home/Filings/4/0000950117-10-000388
4//SEC Filing

Carr Daniel B 4

Accession 0000950117-10-000388

CIK 0000050710other

Filed

Mar 28, 8:00 PM ET

Accepted

Mar 29, 2:38 PM ET

Size

13.5 KB

Accession

0000950117-10-000388

Insider Transaction Report

Form 4
Period: 2010-03-25
Carr Daniel B
DirectorSee Remarks
Transactions
  • Exercise/Conversion

    Stock Option

    2010-03-255,30790,593 total
    Exercise: $1.07Exp: 2019-01-23Common Stock (5,307 underlying)
  • Exercise/Conversion

    Stock Option

    2010-03-2676789,826 total
    Exercise: $1.07Exp: 2019-01-23Common Stock (767 underlying)
  • Exercise/Conversion

    Common Stock

    2010-03-26$1.07/sh+767$821156,668 total
  • Sale

    Common Stock

    2010-03-26$1.35/sh700$945155,968 total
  • Exercise/Conversion

    Common Stock

    2010-03-25$1.07/sh+5,307$5,678160,601 total
  • Sale

    Common Stock

    2010-03-25$1.35/sh4,700$6,345155,901 total
Footnotes (3)
  • [F1]Includes (i) 31,246 shares of common stock, (ii) 5,000 shares of common stock purchased pursuant to the Issuer's Employee Stock Purchase Plan and (iii) 119,048 Deferred Stock Units (DSUs) granted on May 1, 2009.
  • [F2]Granted under the Issuer's Amended and Restated 2005 Stock Incentive Plan.
  • [F3]Vesting in three equal annual installments beginning after the first year.

Issuer

JAVELIN PHARMACEUTICALS, INC

CIK 0000050710

Entity typeother

Related Parties

1
  • filerCIK 0001311634

Filing Metadata

Form type
4
Filed
Mar 28, 8:00 PM ET
Accepted
Mar 29, 2:38 PM ET
Size
13.5 KB